ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,308,099 | -10.7% | 5,050,968 | +7.9% | 0.00% | 0.0% |
Q2 2023 | $61,965,769 | +2.0% | 4,680,194 | +4.9% | 0.00% | 0.0% |
Q1 2023 | $60,745,594 | -30.6% | 4,463,306 | -0.4% | 0.00% | -33.3% |
Q4 2022 | $87,483,093 | +6.4% | 4,479,421 | +3.8% | 0.00% | 0.0% |
Q3 2022 | $82,241,000 | +7.3% | 4,317,157 | +16.0% | 0.00% | +50.0% |
Q2 2022 | $76,659,000 | -28.5% | 3,721,237 | +11.7% | 0.00% | -33.3% |
Q1 2022 | $107,203,000 | +42.7% | 3,331,313 | +106.5% | 0.00% | +50.0% |
Q4 2021 | $75,111,000 | +78.5% | 1,613,228 | +3.5% | 0.00% | +100.0% |
Q3 2021 | $42,072,000 | +8.1% | 1,558,236 | +2.7% | 0.00% | 0.0% |
Q2 2021 | $38,905,000 | -25.8% | 1,516,738 | -1.1% | 0.00% | -50.0% |
Q1 2021 | $52,409,000 | +45.5% | 1,533,322 | +44.0% | 0.00% | +100.0% |
Q4 2020 | $36,009,000 | +120.3% | 1,064,746 | +60.7% | 0.00% | 0.0% |
Q3 2020 | $16,342,000 | – | 662,410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |